Medicine
SKF-38393
SaveA selective dopamine D1 receptor partial agonist used primarily as a pharmacological research tool. Not developed as a therapeutic agent.
Quick verdict
An important D1-selective tool compound in neuroscience research. No clinical development or human therapeutic use.
Evidence score
A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.
What the research shows
Widely used in preclinical research to study D1 receptor function in cognition, motor control, and reward. Partial agonist activity means it can both activate and partially block D1 receptors depending on endogenous dopamine tone. Enabled fundamental discoveries about D1's role in working memory and prefrontal function.
Benefits
- Foundational research tool for understanding D1 receptor function
- Selective D1 partial agonism clarifies receptor-specific effects
Dosage notes
Not applicable — research tool compound with no human dosing.
Side effects
- Not characterized in humans
Who should be cautious
Not a therapeutic agent. Not manufactured for human use. Research-grade compound only.
What this page cannot tell you
Purely a pharmacological tool. Any self-experimentation would be inappropriate and unsupported.
Leaderboard scores
- Focus15
- Memory15
Write a review
Sign in to write a review.